Gilhyang Kim, Yul Ri Chung, Bohyun Kim, Boram Song, & Kyung Chul Moon. (2016). Comparison of the FDA and ASCO/CAP Criteria for HER2 Immunohistochemistry in Upper Urinary Tract Urothelial Carcinoma. Korean Society of Pathologists & the Korean Society for Cytopathology.
Chicago Style (17th ed.) CitationGilhyang Kim, Yul Ri Chung, Bohyun Kim, Boram Song, and Kyung Chul Moon. Comparison of the FDA and ASCO/CAP Criteria for HER2 Immunohistochemistry in Upper Urinary Tract Urothelial Carcinoma. Korean Society of Pathologists & the Korean Society for Cytopathology, 2016.
MLA (9th ed.) CitationGilhyang Kim, et al. Comparison of the FDA and ASCO/CAP Criteria for HER2 Immunohistochemistry in Upper Urinary Tract Urothelial Carcinoma. Korean Society of Pathologists & the Korean Society for Cytopathology, 2016.